These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7714200)

  • 1. Mycobacterial testing in clinical laboratories that participate in the College of American Pathologists' Mycobacteriology E survey: results of a 1993 questionnaire.
    Woods GL; Witebsky FG
    J Clin Microbiol; 1995 Feb; 33(2):407-12. PubMed ID: 7714200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterial testing in clinical laboratories that participate in the College of American Pathologists Mycobacteriology Surveys. Changes in practices based on responses to 1992, 1993, and 1995 questionnaires.
    Woods GL; Long TA; Witebsky FG
    Arch Pathol Lab Med; 1996 May; 120(5):429-35. PubMed ID: 8639044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of mycobacterial testing in clinical laboratories. Results of a questionnaire completed by participants in the College of American Pathologists Mycobacteriology E survey.
    Woods GL; Witebsky FG
    Arch Pathol Lab Med; 1993 Sep; 117(9):876-84. PubMed ID: 8368898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility testing of Mycobacterium avium complex in clinical laboratories. Results of a questionnaire and proficiency test performance by participants in the College of American Pathologists Mycobacteriology E Survey.
    Woods GL; Witebsky FG
    Arch Pathol Lab Med; 1996 May; 120(5):436-9. PubMed ID: 8639045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U.S. hospital mycobacteriology laboratories: status and comparison with state public health department laboratories.
    Tokars JI; Rudnick JR; Kroc K; Manangan L; Pugliese G; Huebner RE; Chan J; Jarvis WR
    J Clin Microbiol; 1996 Mar; 34(3):680-5. PubMed ID: 8904437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Bergmann JS; Woods GL
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):153-6. PubMed ID: 9294706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
    Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. College of American Pathologists Mycobacteriology E Proficiency Testing Survey. Summary of participant performance, 1979-1992.
    Woods GL; Witebsky FG
    Arch Pathol Lab Med; 1995 Jan; 119(1):17-22. PubMed ID: 7802547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi.
    Ndung'u PW; Kariuki S; Ng'ang'a Z; Revathi G
    J Infect Dev Ctries; 2012 Jan; 6(1):33-9. PubMed ID: 22240426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs.
    Bergmann JS; Woods GL
    J Clin Microbiol; 1998 Oct; 36(10):2940-3. PubMed ID: 9738047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast of survey results between state and a cohort of nonstate mycobacteriology laboratories: changes in laboratory practices.
    Denniston MM; Bird BR; Kelley KA
    J Clin Microbiol; 1997 Feb; 35(2):422-6. PubMed ID: 9003609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR.
    Ruiz M; Torres MJ; Llanos AC; Arroyo A; Palomares JC; Aznar J
    J Clin Microbiol; 2004 Apr; 42(4):1585-9. PubMed ID: 15071008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting.
    Yoo IY; Huh HJ; Kang OK; Jhun BW; Koh WJ; Lee NY
    Respir Med; 2019 Jan; 146():71-75. PubMed ID: 30665521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Reisner BS; Gatson AM; Woods GL
    Diagn Microbiol Infect Dis; 1995 Aug; 22(4):325-9. PubMed ID: 8582137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar.
    Coban AY; Bilgin K; Uzun M; Tasdelen Fisgin N; Akgunes A; Cihan CC; Birinci A; Durupinar B
    J Clin Microbiol; 2005 Apr; 43(4):1930-1. PubMed ID: 15815022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current practices in mycobacteriology: results of a survey of state public health laboratories.
    Huebner RE; Good RC; Tokars JI
    J Clin Microbiol; 1993 Apr; 31(4):771-5. PubMed ID: 8463385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.